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FRAS1 is mutated in some individuals with Fraser syndrome (FS) and the encoded protein is expressed in
embryonic epidermal cells, localizing in their basement membrane (BM). Syndactyly and cryptophthalmos
in FS are sequelae of skin fragility but the bases for associated kidney malformations are unclear. We demon-
strate that Fras1 is expressed in the branching ureteric bud (UB), and that renal agenesis occurs in homozy-
gous Fras1 null mutant blebbed (bl) mice on a C57BL6J background. In vivo,t h ebl/bl bud fails to invade
metanephric mesenchyme which undergoes involution, events replicated in organ culture. The expression
of glial cell line-derived neurotrophic factor and growth-differentiation factor 11 was defective in bl/bl renal
primordia in vivo, whereas, in culture, the addition of either growth factor restored bud invasion into the
mesenchyme. Mutant primordia also showed deﬁcient expression of Hoxd11 and Six2 transcription factors,
whereas the activity of bone morphogenetic protein 4, an anti-branching molecule, was upregulated. In wild
types, Fras1 was also expressed by nascent nephrons. Foetal glomerular podocytes expressed Fras1 tran-
scripts and Fras1 immunolocalized in a glomerular BM-like pattern. On a mixed background, bl mutants,
and also compound mutants for bl and my, another bleb strain, sometimes survive into adulthood. These
mice have two kidneys, which contain subsets of glomeruli with perturbed nephrin, podocin, integrin a3
and ﬁbronectin expression. Thus, Fras1 protein coats branching UB epithelia and is strikingly upregulated
in the nephron lineage after mesenchymal/epithelial transition. Fras1 deﬁciency causes defective interactions
between the bud and mesenchyme, correlating with disturbed expression of key nephrogenic molecules.
Furthermore, Fras1 may also be required for the formation of normal glomeruli.
INTRODUCTION
Fraser syndrome (FS; OMIM #219000) is an autosomal reces-
sive disorder occurring in 11/100 000 stillbirths and 0.4/
100 000 livebirths and characterized by cryptophthalmos
(eyeball covered by skin), syndactyly (fused digits) and kidney
malformations (1,2). Winter (3) suggested that bleb mutant
mice are models for human FS, with four lines affected by
ocular, digital and renal anomalies. Both blebbed (bl)a n dmye-
lencephalic blebs (my) homozygous embryos undergo epider-
mal–dermal dehiscence below the plane of the basement
membrane (BM). Incomplete healing of resulting haemorrhagic
blisters causes cryptophthalmos and soft tissue syndactyly (4,5).
Byanalogywithblebmice,humanFSsurfacemalformationsare
considered sequelae of embryonic skin fragility (3,5).
Some FS individuals have mutations in either FRAS1 or
FRAS1-related extracellular matrix (ECM) gene 2 (FREM2),
and Fras1 and Frem2 are, respectively, implicated in bl and
my bleb mice (6–9). Fras1 and Frem2 are transmembrane pro-
teins containing an extracellular repeated chondroitin sulphate
proteoglycan domain, and the extracellular, N-terminal domain
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cysteine-richpartialfurinmotifs(5).Fras1andFrem2transcripts
areexpressedinembryonicepidermis,immunolocalizinginsub-
lamina densa of the BM, whereas Frem1, a related protein
lacking a transmembrane domain and mutated in head blebs
mice, is expressed by adjacent stroma (10,11). Normal mouse
skin contains Fras1/Frem1/Frem2 protein complexes, whereas
bleb mutants have defective assembly of this ECM complex (4).
The metanephros initiates by interactions between ureteric
bud (UB) epithelia and metanephric mesenchyme (MM).
MM-generated glial cell line-derived neurotrophic factor
(Gdnf) stimulates UB growth via the Ret receptor, and both
Gndf and Ret null mutants have renal agenesis (12,13). Growth-
differentiation factor 11 (Gdf11) is, like Gdnf, a distant member
of the transforming growth factor b (Tgfb) superfamily, and it is
expressed in metanephric primordia with its receptor, ActRIIB
(14). Gdf11 null embryos have deﬁcient Gdnf expression in
MM and renal agenesis (14). Bone morphogenetic protein 4
(Bmp4) expression around the mesonephric duct (MD) prevents
ectopicUBformationviapathwaysphosphorylatingSmad1/5/8,
and Bmp4 expression activity is minimal where the normal UB
emerges (15,16). During UB growth into the MM, the latter’s
cells are rescued from apoptosis and become compactly orga-
nized around the bud (17). Induced MM changes its pattern of
gene expression such that ﬁbronectin is downregulated,
whereas Bcl2, an anti-apoptosis molecule, and integrin a8
(Itga8)areupregulated(18–21).Itga8onMMcellsurfacesmed-
iates interaction with the UB and, by an undeﬁned mechanism,
maintains MM Gdnf expression (22). MM also expresses tran-
scription factors controlling nephrogenesis, including the
homeobox 11 (Hox11) family, paired-box 2 (Pax2), sal-like 1/
homologue of Drosophila spalt 1 (Sall1), sine oculis Drosophila
homologue (Six) 1 and 2 and Wilms tumour 1 (Wt1) (23–33).
Thus, metanephric initiation is mediated by growth factors,
ECM molecules and transcription factors.
FS individuals often have absent kidneys (bilateral in 20–
40% or unilateral in 20–40%), and 10% also have absence
of one or both ureters (1). Postnatally, most FS individuals
die in the ﬁrst year because of kidney failure and/or upper
airway atresias, another feature of the syndrome (1). When
human FRAS1 and mouse Fras1 mutations were ﬁrst reported,
it was demonstrated that Fras1 transcripts were expressed in
mouse MDs and their UB branches, with Fras1 immunoloca-
lized in a BM-like pattern around these epithelia (6,7). It
was subsequently found that Fras1 is also expressed as the
UB lineage branches into collecting ducts (CDs) (34–36).
Beyond these observations, the bases for renal defects in FS
and bl mice were unknown, and there was no information
about the expression of nephrogenic genes in bl renal primordia.
It was also unclear whether Fras1 was expressed in the nephron
lineage. We demonstrate that Fras1 is expressed in UB branches
and that renal agenesis occurs with high penetrance in homozy-
gous Fras1 null mutant blebbed (bl)m i c em a i n t a i n e di na
C57BL6J background. In this context, Fras1 deﬁciency causes
defective interaction between the UB and MM, correlating
with disturbed expression of speciﬁc nephrogenic molecules.
We also show that Fras1 is upregulated as MM differentiates
into nephrons, with Fras1 immunolocalizing in nascent glomer-
uli in a BM-like pattern, and we demonstrate that bl and my
mutants maintained in a mixed background sometimes survive
into adulthood; these mice have two kidneys, which contain
subsets of defective glomeruli. Thus, the data presented in this
paper not only explain how Fras1 is needed for the initiation
ofthemetanephrickidneybutalsosuggestthatthisECM-related
protein has a function at a later stage of development, namely in
the formation of glomeruli, ﬁltering units of the kidney.
RESULTS
Fras1 expression
We sought Fras1 expression in wild-type mice by in situ
hybridization (ISH) and immunohistochemistry (IHC). At
embryonic day (E) 11, Fras1 transcripts were noted in the
UB and its ﬁrst branches (Fig. 1A and B). ISH signals above
background levels were not detected in MM (Fig. 1B). Fras1
protein was detected as a ﬁne linear signal on the basal
aspect of the UB stalk and its ﬁrst branches, but the signal
did not extend outwards into the MM (Fig. 1C). Views of
E12–16 metanephroi (Fig. 1D–F) revealed that Fras1 tran-
scripts and protein were expressed in nephrons and UB deriva-
tives. Fras1 transcripts were not only detected in branching
UB tips but also in adjacent vesicles, nephron precursors
which have undergone mesenchymal to epithelial transform-
ation (Fig. 1G). Fras1 immunolocalized in a linear pattern
around UB branches but in a cytoplasmic pattern in vesicles
(Fig. 1H). Fras1 transcripts were expressed in S-shaped
bodies (Fig. 1I), where, in the proximal limb, Fras1 was immu-
nodetected in a linear pattern on basal aspects of parietal
(Bowman’s capsule) and visceral (podocyte) epithelia in the
nascent glomerulus (Fig. 1J). In capillary loop-stage glomer-
uli, podocytes expressed Fras1 transcripts (Fig. 1K), with
protein detected on their basal aspects in a wavy, linear
pattern (Fig. 1L and M). This pattern of Fras1 protein contrasts
with that of Wt1, located in podocyte nuclei (37), and is
similar to IHC patterns of podocin and Itga3 (Fig. 1N–P),
both located on basal surfaces of podocytes (38,39).
Renal agenesis in bl mutant embryos in vivo
The background of the original bl mutant strain is unknown
(40). Using a bl colony maintained in a C56BL6J background
for over ﬁve generations, we assessed embryos immunostained
for Pax2, which is expressed by MDs, UBs and by uninduced
and induced MM (25). In all 30 wild-type (þ/þ) embryos,
UB initiation and interaction with MM occurred in E10–11
(Fig. 2A–D). In 23 bl/bl embryos studied in E10–11, UBs
usually failed to sprout (Fig. 2E–H) or, if they did, they
nearly always failed to enter the MM (Fig. 2I–L). Of 16 E11
bl/bl embryos, seven demonstrated bilateral absent UBs, six
had unilateral absent UB and a contralateral UB stump, two
had bilateral UB stumps and one had unilateral absent UB
and contralateral overtly normal metanephros. Neither physical
blebs nor UB ectopia nor duplex UBs were detected, and meso-
nephroi and adrenal glands were grossly normal (not shown).
Induction markers, expression of Gdnf and Gdf11
and cell turnover in vivo
In wild-type E11 MMs, harmonizing with UB penetration and
consistent with MM induction, MM expressed Itga8 and Bcl2
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however, expressed ﬁbronectin, whereas Itga8 and Bcl2
signals were barely detectable (Fig. 2P–R). Because Gdnf
and Gdf11 null mutants have failed UB progression similar
to bl/bl mice, and because Fras1 contains N-terminal chordin-
like domains similar to those binding Tgfb family proteins (5),
we explored the expression of Gdnf and Gdf11. In E10–11
wild-types, Gdf11 transcripts were detected in MD, UB and
MM but signals were barely detectable in bl/bl primordia
(Fig. 2S and T; data not shown). E10–11 wild-type MMs
expressed Gdnf, whereas bl/bl MMs demonstrated reduction
at E10 and profound attenuation at E11, a kidney-speciﬁc
effect because normal Gdnf expression occurred in gut
mesenchyme (Fig. 2U and V; not shown). Ret was expressed
in MDs and UBs of wild-type embryos, and bl/bl mutants had
similar expression in MDs and in variably present UB stumps
(Fig. 1W and X). Most MM nuclei in E11 wild-type and
mutant MMs contained proliferating cell nuclear antigen
(PCNA) (Fig. 2Y and Z). Although apoptosis was rare in wild-
type MMs, up to 20% of nuclei in E11 bl/bl MMs were posi-
tive using terminal deoxynucleotidyl transferase-mediated
DUTP nick end-labelling (TUNEL) (Fig. 2A0 and B0), and
similar proportions of cells expressed activated capsase 3 as
assessed by IHC (data not shown).
Figure 1. Fras1 expression in wild-type metanephroi. (A), (B), (D), (F), (G), (I) and (K) are of ISH, and (C), (E), (H), (J) and (L–P) are of IHC. Sections in (C)
and (M) were counterstained with haematoxylin. (A) Fras1 transcripts (black) in the E11 UB stalk and branches within the metanephros (oval in left of frame).
Fras1 was also expressed in the MD and in mesonephric tubules (mesonephros/gonadal ridge is the elongated structure in the centre and right of frame).
(B) Higher power of an E11 metanephros: ISH Fras1 signal in UB branches (outlined by white dashes). (C) Fras1 protein was detected as a ﬁne (brown)
line on basal surfaces of E11 UB stalk and branches (note the lack of positive signal in cell layers of surrounding MM). (D), (E) and (F) Respective low-power
views of Fras1 ISH at E12, IHC at E15 and ISH at E16. Note Fras1 expression (black) in diverse epithelial structures. (G) and (H) High-power views of E16
nephrogenic cortex showing Fras1 transcripts in UB branches and adjacent vesicle [arrowed in (G)], with Fras1 immunolocalized in a linear pattern around the
UB branches [u in (H)] and in a cytoplasmic pattern in a nephron vesicle [arrow in (H)]. (I) and (J) High-power views of E16 deeper cortex showing an S-shaped
body, with the proximal limb to the left and distal limb to the right. Fras1 transcripts [black in (I)] were detected in both limbs with protein detected in a linear
pattern on glomerular epithelia (J): the left-hand crescent is Fras1 on the basal aspect of parietal epithelia, whereas the inner crescent is the basal aspect of
immature, columnar podocytes. (K)–(P) Capillary loop-stage glomeruli in E16 metanephros. (K) Fras1 transcripts (black) in glomerular epithelia. (L) and
(M) Fras1 immunolocalized [black in (L) and brown in (M)] in a wavy, linear pattern at the basal aspect of podocytes. (N), (O) and (P) Frames, respectively,
show ICH for Wt1, podocin and Itga3, with positive signals in black. Note the similarity of the Fras1 ICH pattern to that of Itga3, and to a lesser extent, podocin.
Bars in (A), (D), (E) and (F) are 200 mm; bars in (B) and (C) are 100 mm; bars in (G)–(P) are 25 mm.
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Overviews of explanted nephrogenic ﬁelds (paired MDs and
MMs) are shown in Figures 3 and 4, and gene expression in
Figure 4. In E10–11 wild-type explants (n ¼ 5) cultured for
48 h, UBs invariably grew into MMs (n ¼ 10), which became
induced as assessed by the compaction of MM cells around
the incoming bud and the facts that MM expressed Bcl2 and
Itga8 but little ﬁbronectin (Fig. 4A–E). In contrast, all time-
matched bl/bl explants (n ¼ 5) recapitulated their in vivo fates;
although a UB sometimes grew towards its MM, it never
entered it, and MMs (n ¼ 10) contained unorganized cells
expressing ﬁbronectin but not Bcl2 or Itga8 (Fig. 4F–J).
Using these outcomes, there were signiﬁcant differences
between wild-types and mutants (Fisher’s exact test, two-tail
P ¼ 0.008 for explants and P ¼ 0.00001 for metanephroi).
When E10–11 wild-types (two explants/four metanephroi) and
time-matched mutants (three explants/six metanephroi) were
cultured to 72 h, all wild-type metanephroi formed organs with
branched UBs and nascent nephrons, whereas all mutants
showed progressive involution (Fig. 3A), thus showing that
mutant MM differentiation was seriously disrupted, rather than
being delayed. When wild-type E10–11 explants were cultured
with recombinant human (h) GDNF (100 ng/ml) for 48 h, two
UBs often arose from the MD (not shown), with similar
results in mutants, indicating that their MDs, which express
Ret, respond to this growth factor (Fig. 4K and L) even in the
absence of functional Fras1. hGDNF-treated E10–11 mutant
renal tract explants (n ¼ 4) contained MM cells condensed
around the incoming UB in all eight metanephroi and immuno-
probing for Itga8, Bcl2 and ﬁbronectin suggested that MMs had
initiated a normal programme of gene expression (Fig. 4M–O).
In bl/bl explants (n ¼ 4) cultured for 48 h with hGDF11 (50 ng/
ml), a single-UB grew from each MD into each of the MMs,
forming eight discrete metanephroi with condensed MM expres-
sing Bcl2 and Itga8 but not ﬁbronectin (Fig. 4P–T). For treat-
ment with either factor, there was a signiﬁcantly improved
outcome versus untreated mutants (P ¼ 0.03 for explants and
P ¼ 0.0001 for metanephroi). When E10–12 mutant explants
(n ¼ 4) were cultured for extended periods (72–96 h) with
both growth factors, all eight metanephroi underwent develop-
ment beyond the stage of UB in-growth, with histology
showing some early nephron formation. However, mutant
metanephroi appeared smaller versus time-matched wild-types
(n ¼ 4 explants/8 metanephroi) treated similarly (Fig. 3B).
When we explanted three older (E13–14) bl/bl explants,
Figure 2. In vivo bl/bl phenotypes, gene expression and cell turnover. (A)–(C), (E)–(G) and (I)–(K) are wholemounts immunostained for Pax2 marking MD, UB
and both uninduced and induced MMs in black; (D), (H), (L)–(R), (Y), (Z), (A0)a n d( B0) were counterstained with haematoxylin. Sections in (M)–(R) and (Y), (Z),
(A0) and (B0) underwent IHC (positive brown signal); sections in (S)–(X) underwent ISH (positive black signal). Wild-type E10 (A), E10.5 (B) and E11 [(C) and
(D)] renal tracts showing UB initiation from the MD and growth into MM. (E)–(H) bl/bl renal tracts at E10 (E), E10.5 (F) and E11 [(G) and (H)] in which UBs fail
to initiate. (I)–(L) bl/bl mutants at E10 (I), E10.5 (J) and E11 [(K) and (L)], where UBs sprout but fail to enter MM [indicated by ‘ ’ in (K)]. (M)–(R) Wild-type
MMs downregulated ﬁbronectin and upregulated Itga8 and Bcl2. Mutant MMs expressed ﬁbronectin but not signiﬁcant levels of Itga8 and Bcl2. (S)–(X) Gdnf
expression and Gdf11 expression were deﬁcient in bl/bl MMs, whereas mutant MDs and UB stumps expressed Ret [arrows in (X)]. Dotted lines in (W) and
(X) outline the MM. (Y) and (Z) IHC for PCNA. Note that this surrogate marker of proliferation was detected in most nuclei of wild-type and mutant MMs
(brown nuclei). (A0)a n d( B 0) TUNEL probe. Note numerous apoptotic nuclei (red) in bl/bl MM but not in wild-type MM. Bars in all frames are 100 mm.
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predictable result given that MMs would have already involuted
in vivo (6).
Expression of transcription factors and Bmp4
signalling in vivo
We sought the expression of diverse other genes implicated in
metaneprhic induction, as outlined in the Introduction. E10–11
bl/bl MMs showed defective expression of Hoxd11 and Six2
(Fig. 5A–D), whereas the expression of Pax2, Wt1, Eya1,
Six1 and Sall1 was normal (Fig. 5E–P). In E10 wild-types,
we detected Bmp4 transcripts and weak immunohistochemical
signals for phospho-Smad1/5/8in sparse cells around UB stalks
(Fig. 5Q–S). In contrast, in bl/bl embryos, several layers of
cells between the MD and MM expressed Bmp4 accompanied
by prominent phospho-Smad1/5/8 (Fig. 5T–V).
bl and my mutants in a mixed background
When bl and my alleles were maintained in a mixed back-
ground, by interbreeding the original bl colony with the my
allele which was in an NMRI background, some mice homo-
zygous for bl or my or my/bl (e.g. 45% bl/bl and 72% my/my
mice) survived to adulthood (8,40). We previously reported
that the kidneys of these mutants, at 6–9 months of age, con-
tained sporadic cysts usually arising from CDs (8). Having
now found that Fras1 was expressed by foetal podocytes,
mutant kidneys were re-examined with a focus on glomeruli.
Subsets of glomeruli (10–20%/section) in kidneys of three
of four compound homozygous bl/my mutants were abnormal,
whereas glomeruli in wild-type or heterozygous bl and/or my
mice (n ¼ 7) were normal (Fig. 6). Segments of bl/my glomer-
uli lacked nuclei (Fig. 6A and B) and the normal patterns of
nephrin (Fig. 6C and D), Itga3 (Fig. 6E and F), (pan)laminin
(Fig. 6G and H) and podocin (Fig. 6I and J) were lost. Further-
more, the delicate looped pattern of ﬁbronectin was replaced
by a mesangial signal (Fig. 6K and L). In this collection (8),
the two bl/bl mutants which were wild type in the my locus
also had subsets of glomeruli with abnormal patterns of
Itga3, (pan)lamin and ﬁbronectin (Supplementary Material,
Fig. S1). Finally, similar lesions were noted in the kidneys
of an extraordinary bl/bl adult survivor in the C56BL6J
colony (not shown); it had syndactyly and cryptophthalmos
Figure 3. bl/bl renal tract explants. (A) Representative examples of E10/11 renal tracts cultured without added hGDNF or hGDF11 (E10/11—no added growth
factors). Each explant contained paired MDs and adjacent MMs. In the wild type, note progressive growth of two metanephroi containing Pax2-expressing UB
branches and immature nephrons. Contrast this with the failure to initiate discrete metanephroi in the bl/bl mutant explant from the same litter. In the Pax2-
immunostained bl/bl wholemount, although the MDs and disorganized MMs are detected, no UBs are visible after 72 h culture. The area in the box in the Pax2-
stained bl/bl wholemount picture is depicted, in a histology section, in the adjacent frame. (B) Representative examples of E10/11 renal tracts cultured with both
growth factors (E10/11—with added growth factors; see main text for details). Metanephroi formed in both wild-type and mutant explants, and both contained
UB branches and nephron vesicles; however, the mutant kidneys were smaller. (C) When older (i.e. E13–14) explants were explanted in the presence of both
growth factors (E14 with added growth factors), mutant metanephroi could not be rescued. As depicted in the Pax2-stained wholemount frame, although the two
MDs were present, no UBs or MMs were detected after 72 h culture. In (A), bars in wholemount frames are 100 mm and bars in histology frames are 25 mm; in
(B), bars in wholemount frames are 200 mm and bars in histology frames are 25 mm; in (C), all bars are 200 mm.
Human Molecular Genetics, 2008, Vol. 17, No. 24 3957and was sacriﬁced at 4 months of age owing to failure to
thrive. Notably, all mutants in the mixed background had
two kidneys.
DISCUSSION
Fras1 is expressed by both the UB and the nephron
lineages in the mammalian kidney
Our study supports reports that state Fras1 is expressed in the
UB lineage (6,7,34–36). At E11, Fras1 IHC signal closely sur-
rounded the UB stalk and its branches and did not extend
outwards into the several MM cell layers. Fras1 does,
however, become prominently expressed in the nephron
lineage after the MM/epithelial transformation. Fras1 was
prominently expressed in vesicles, which are epithelial spher-
oids arising from MM aggregates. We interrogated the
GenitoUrinary Development Molecular Anatomy Project
(http://www.gudmap.org/) and noted that Fras1 had been
detected in certain expression microarray experiments
using microdissected MM from E11–12 metanephroi. In one
set, however, Ret was also expressed, perhaps most consistent
with UB contamination. The ISH and IHC techniques we
used would be unable to detect very low levels of Fras1
transcripts and protein, and thus it remains possible that
Fras1 expression initiates in the MM prior to epithelial
transformation. Fras1 protein was detected in a cytoplasmic
pattern in vesicles, whereas it was immunolocalized on the
basal aspects of epithelia in S-shaped bodies and foetal glo-
meruli. In the UB and its branches, Fras1 protein was also
detected as a line on cells’ basal aspect. Hence, by analogy
with foetal skin (4,11), Fras1 most likely exists as a
BM-associated protein in both UB/CD and nephron epithelia.
Fras1 complexes with Frem2 in embryonic skin (4), and
Figure 4. Gene expression in renal tract explants. This panel depicts E10 explants after 48 h serum-free culture. All were wholemount-immunostained with
antibody to Pax2 which labels MDs, UBs and both uninduced and induced MMs. (A), (F), (K) and (P) are wholemounts with Pax2 signal appearing black.
(B)–(E), (G)–(J), (L)–(O), (Q)–(T) frames are histology sections of whole mounts; in (B), (G), (L) and (Q), the Pax2 signal is black, whereas the signal
appears brown in remaining frames. (A)–(E) Wild types show UB penetration into condensing, induced MM expressing Itga8/red and Bcl2/blue, but
lacking MM ﬁbronectin/red (note that surrounding non-renal mesoderm does express ﬁbronectin). (F)–(J) bl/bl explants show failure of both UB growth and
MM induction with minimal expression of MM Itga8 (red) and Bcl2 (blue), but prominent ﬁbronectin (red). Addition of hGDNF [(K)–(O)] or hGDF11
[(P)–(T)] to bl/bl explants allowed the formation of discrete metanephroi with penetrated UBs and aggregated and which expressed Itga8 (red) and Bcl2
(blue) but little ﬁbronectin (red). In double-immunostained sections, nuclear signals for Pax2 are brown, and these signals are detected in both induced and
uninduced MMs, and also in MDs and UBs. In (A), (F), (K) and (L), bars are 200 mm; in all other frames, bars are 75 mm.
3958 Human Molecular Genetics, 2008, Vol. 17, No. 24Frem2 is also expressed by UB branches, vesicles, S-shaped
bodies and nascent glomeruli (our unpublished data and
8,36,40).
Lack of Fras1 causes renal agenesis in the C57BL6J
background, correlating with defective expression
of key nephrogenic molecules
The bl strain contains a 7313CC!AA Fras1 mutation, result-
ing in a premature stop codon and rendering this a null
mutation; indeed, similar phenotypes occur in mice with
genetically engineered null Fras1 mutation (6,7). We found
that Fras1 deﬁciency is associated with failed UB growth
between E10–11 in vivo and, consistent with failed UB pen-
etration, bl/bl MMs remained uninduced and were apoptotic.
Indeed, apoptotic involution is the default pathway of unin-
duced MM (17). The observations explain the facts that
kidneys and ureters are often undetectable in late gestation
Fras1 null mutant mice and in FS individuals (1,6,7). The
lack of UB growth in bl/bl embryos in vivo was associated
with Gdnf deﬁciency. Our experiments show that Ret
remains expressed in Fras1 null mutant MDs, and that these
structures can be stimulated to produce UBs by hGDNF,
even in the absence of Fras1 protein which normally coats
the MD and UB (6). In future, a more prolonged rescue
might be obtained in vivo by upregulating Gdnf/Ret signalling
in Fras1 mutant mice by introducing a heterozygous Sprouty1
mutation, as used to rescue Itga8 mutants (22).
Gdf11 ablation causes metanephric Gdnf deﬁciency in vivo
(14) and we found that Gdf11 expression was downregulated
from E10 in bl/bl renal tracts; furthermore, the addition of
hGDF11 in organ culture stimulated UB growth in mutants.
One can therefore postulate that Gdf11 deﬁciency is upstream
to the Gdnf deﬁcit in bl/bl renal primordia (Fig. 7). It is,
however, unknown why a lack of Fras1 is associated with
Gdf11 deﬁciency. Perhaps an Fras1/Frem1/Frem2 complex
(4) has ‘outside-in’ signalling functions controlling the
expression of Gdf11 and/or Gdnf; indeed, Frem1 has an
Figure 5. Expression of transcription factors and Bmp4. (A)–(P) are sections from E11 animals when, in wild types, the UB has undergone one round of branch-
ing within the MM. (Q)–(V) are E10.5 embryos, where the wild-type UB had just penetrated the MM. Positive expression signals are black in (A), (B), (E), (F),
(K), (L), (Q), (R), (T) and (U); in other frames, positive IHC signals are brown. (C), (D), (G)–(J), (M)–(P), (S) and (V) were counterstained with haematoxylin.
(A) and (B) ISH for Hoxd11 and (C) and (D) IHC for Six2 showing downregulated expression in bl/bl MMs. (E)–(P) Several other genes showed similar inten-
sity of signal in wild-type and mutant MMs: Pax2 ISH [(E) and (F)]; Pax2 IHC [(G) and (H)]; Wt1 IHC [(I) and (J)]; Eya1 ISH [(K) and (L)]; Six1 IHC [(M) and
(N)]; Sall1 IHC [(O) and (P)]. (Q)–(V) Bmp4 ISH depicted in (Q) and (T), whereas other frames are IHC for phospho-Smad1/5/8. Note that (S) and (V), respect-
ively, are frames (R) and (U) counterstained with haematoxylin. In wild-types, Bmp4 transcripts were detected around UB stalks, with weak signal for
phospho-Smad1/5/8 in this location. In bl/bl littermates, Bmp4-expressing cells were detected between the MM and unbranched MD, with several cell layers
expressing phospho-Smad1/5/8 in this location. Stars have been placed next to MDs, and arrows indicate normal UB stalk in wild types and an abnormal
UB stump in the bl/bl embryo; in the wild-type frames, ‘u’ indicates the UB within the MM and, in the bl/bl fames, ‘m’ indicates the un-penetrated MM.
Bars in all frames are 100 mm.
Human Molecular Genetics, 2008, Vol. 17, No. 24 3959integrin-binding motif (41). We noted that, in vivo, bl/bl MMs
also had deﬁcient expression of transcription factors Hoxd11
and Six2, both regulators of metanephrogenesis (31,33). At
least in non-metanephric contexts, Gdf11 upregulates
Hoxd11 (42). In addition, a Hox11–Eya1–Pax2 complex acti-
vates Six2 and Gdnf in MM (32), Six2 itself can upregulate
Gdnf (30) and Hox11 upregulates Itga8 in MM (28). Bmp4
expression and signalling, as assessed by phospho-Smad1/5/
8 expression, was upregulated between MDs and MMs.
Given that Bmp4 inhibits UB outgrowth (15,16), this provides
another reason, as Gdnf deﬁciency, for failed UB initiation in
Fras1 mutants; upregulated Bmp4 signalling is also consistent
with the fact that we never observed duplex UB outgrowths.
The data are also consistent with the hypothesis that chordin-
like domains in Fras1 bind to Bmp4 and downregulate its
activity (5). Indeed, the overexpression of Fras1 chordin-like
cysteine-rich repeats downregulate phospho-Smad1 in
NIH3T3 cells, without changing total Smad1 (40). Gdf11
downregulates Smad1 phosphorylation when expressed
in Xenopus ectoderm (43), so Gdf11 deﬁciency in bl/bl
embryos provides another possible explanation for phospho-
Smad1 upregulation.
Hence, one can construct a putative network of molecules
directly or indirectly controlled by Fras1 coating the UB
(Fig. 7). In future, a comprehensive picture of gene expression
of bl primordia could be sought using microarrays, as per-
formed with Wnt4 mutant metanephroi (44). Furthermore,
investigating the effects of added growth factors, such as
Gdnf and Gdf11, on isolated Fras1 mutant MDs stripped of
their surrounding mesenchyme (45) may in future add extra
mechanistic insights beyond those obtain from the renal tract
cultures, as described in this study.
The possible roles of Fras1 in renal epithelia
beyond induction of the metanephros
The widespread expression patterns of Fras1 lead to the
hypothesis that epithelial-derived Fras1 plays roles in the
biology of not just the UB but also CDs and glomeruli. Inter-
estingly, poorly differentiated, hypoplastic and/or cystic
kidneys have been reported in non-agenesis FS renal tracts
(1) and we reported that, in Fras1/Frem2 mutants in a
mixed background, kidneys sometimes formed and they
contain cysts, some reacting with markers of CDs (8). We
can now extend these observations to show that these
kidneys contain subsets of glomeruli which have segmental
lesions with the diminished expression of nephrin, podocin
Figure 6. Histology from wild-type and double-mutant bl/my mice in a mixed background. (A), (C), (E), (G), (I) and (K) are wild-type kidneys, whereas (B),
(D), (F), (H) and (J) are double-mutants. Sections in (A) and (B) were counterstained with haematoxylin and eosin. Other sections were not counterstained and
positive IHC signals are black. (A) and (B) Note the segmental, relatively acellular areas in the mutant. (C)–(H) Note the loss of the normal patterns of nephrin
[(C) and (D)], Itga3 [(E) and (F)], (pan)laminin [(G) and (H)] and podocin [(I) and (J)] in bl/my mutant glomeruli. (K) and (L) Note the delicate loop-like pattern
of ﬁbronectin in the wild-type glomerulus and the loss of this pattern and accentuation in the mesangial core in the mutant. Bars in all frames are 100 mm.
Figure 7. Fras1 protein may enhance metanephric initiation via several path-
ways. (A) Putative network of metanephric effector molecules which may be
ultimately regulated by Fras1, an ECM-related protein which coats the surface
of the UB. Beyond Fras1 itself, the expression of the molecules are altered in
bl/bl renal primordia, as demonstrated in the current paper, and several of them
have additionally been shown to regulate other molecules depicted in the
scheme. See the main text for details and references cited for this ﬁgure.
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(38,46,47) and increased mesangial ﬁbronectin. The data are
compatible with the theory that Fras1 and Frem2 are essential
for glomerulogenesis; alternatively, they may be required to
maintain normally formed glomeruli. Support for the former
contention comes from a study (48) in which increased mesan-
gial matrix in adult my mice was preceded by increased glyco-
saminoglycans in developing glomeruli. In our current study,
however, the coincidence of cystic and glomerular lesions
means that we cannot draw ﬁnal conclusions concerning
roles of Fras1 in CDs or glomeruli. In future, targeted CD
(49) or podocyte (50) ablation of Fras1 in a uniform back-
ground will be used to understand the genesis of CD cysts
and glomerular lesions.
Human genetic diseases which cause both renal
agenesis and glomerular defects
The facts that Fras1 is a BM-related protein coating the
surface of the UB and is also expressed nascent podocytes
are highly reminiscent of the expression patterns of
anosmin-1, a BM-related protein which is mutated in
X-linked Kallmann syndrome (51). Affected individuals with
Kallmann syndrome can have unilateral or bilateral renal
agenesis, and in the former case, progressive renal failure
accompanied by proteinuria can occur in adulthood (52).
More rarely, affected individuals can have cystic kidney mal-
formations (53), consistent with defective epithelial morpho-
genesis. Reports of adults with FS are very rare, although
we note that one individual who survived 96 years has been
described (54). She was found to have a solitary kidney and
moderate renal failure with both proteinuria and haematuria,
the latter ﬁnding perhaps consistent with a glomerular lesion
beyond that simply associated with hyperﬁltration nephropa-
thy as might occur in a solitary kidney with ‘overworked’ glo-
meruli (55). Having said this, the FS mice with glomerular
lesions described in this paper had two kidneys.
We consider that FS and X-linked Kallmann syndrome
should be regarded as founding members of a group of
human diseases in which the mutated gene codes for a
BM-associated protein which plays critical roles both at the
start and also towards the end of kidney development, by
virtue of the encoded proteins having a widespread distri-
bution within the kidney. In Table 1 we compare features of
FS and X-linked Kallmann syndrome, and we add a third dis-
order to the group, namely the recently described syndrome of
haematuria and kidney cortical and medullary cysts caused by
the mutation of COL4A1, the gene which codes for the a1
chain of collagen IV located in both glomerular and kidney
tubular BMs (56,57). Finally, we suggest that variants of
the FS genes such as FRAS1 and FREM2 should be consi-
dered as candidates in humans with congenital glomerular
defects which cannot be explained by mutations of known
podocyte genes such as those encoding nephrin and podocin
proteins (47).
Conclusions
Fras1 protein coats branching UB epithelia and is also strik-
ingly upregulated in the nephron lineage after mesenchymal/
epithelial transition. Fras1 deﬁciency causes defective inter-
actions between the bud and mesenchyme, correlating with
disturbed expression of key nephrogenic molecules. Further-
more, Fras1 not only initiates kidney development but may
also be required for the formation of normal glomeruli.
MATERIALS AND METHODS
Animals
Experiments were conducted with the UK Home Ofﬁce per-
mission. bl mice, originally obtained from MRC Mammalian
Genetics Unit (Harwell), were studied in a C57BL/6 back-
ground apart from bl/my compound mutants which were
from a local colony, as described (8). Genotypes were deter-
mined by PCR (details available on request). Heterozygous
parents were timed-mated and embryos collected in PBS and
ﬁxed in 4% paraformaldehyde (PFA) for histology, whole-
mount IHC or ISH. Dehydrated embryos were embedded in
parafﬁn or stored at 2208C in methanol for wholemount
immunostaining. Embryos used to derive tissues for in vitro
culture were collected into ice-cold L15 medium (Invitrogen).
Immunostaining, ISH and apoptosis detection
Primary antibodies used were rabbit anti-Bcl2 (Calbiochem),
rabbit anti-cleaved caspase (Cell Signalling), rabbit anti-
ﬁbronectin (DAKO), rabbit anti-Fras1 (7), rabbit anti-Itga3
(Pharmingen), rabbit anti-Itga8 (a gift from U. Muller,
Scripps Research Institute, La Jolla, CA, USA), mouse
anti-pan laminin (Chemicon), rabbit anti-nephrin (a gift from
H. Holthoffer, University of Helsinki, Finland), rabbit
anti-Pax2 (Zymed), mouse anti-podocin (Santa Cruz), mouse
Table 1. Inherited diseases caused by mutations of genes coding for proteins localized both in glomeruli and in tubule BMs
Disease Mutation (inheritance) Spectrum of kidney disease Extra-renal disease
FS FRAS1FREM2
(autosomal
recessive)
Uni- or bilateral kidney agenesis, cystic
dysplastic kidneys and (in rare adult
survivors) proteinuria and haematuria
Cryptophthalmos, cutaneous syndactyly,
ambiguous genitalia, larynx atresia and anal
atresia/stenosis
X-linked Kallmann syndrome KAL-1 (X-linked
recessive)
Uni- or bilateral kidney agenesis, cystic
dysplastic kidneys and proteinuria in adults
with solitary functioning kidneys
Anosmia and hypogonadotrophic
hypogonadism
HANAC (hereditary angiopathy,
nephropathy, aneurysms and
cramps) syndrome
COL4A1 (autosomal
dominant)
Haematuria and renal cortical and medullary
cysts
Myopathies with cramps and intracranial
aneurysms
Human Molecular Genetics, 2008, Vol. 17, No. 24 3961anti-Sall1 (R&D Systems), mouse anti-PCNA (BD Pharmin-
gen), rabbit anti-Six1 (Cemines), rabbit anti-Six2 (Afﬁnity
Bioscience), rabbit anti-pSMAD1/5/8 (Cell Signalling), rabbit
anti-Wt1 (Santa Cruz). All antibodies required HIR with
citric acid buffer, or with Retriewagen A or B (Pharmingen).
Secondary antibodies were HRP- or AP-conjugated and
signals generated with DAB chromogen (DAKO), or for alka-
line phosphatase with Fast-Red (DAKO) or with BCIP/NBT
(Roche). Wholemount immunostaining was performed as
described (58). Specimens were rehydrated into PBS and
endogenous peroxidase inactivated with 3% hydrogen peroxide.
Specimens were incubated with primary antibody and then
washed and incubated with HRP-conjugated secondary anti-
body. Colourimetric reaction was with DAB (DAKO). ISH
was performed on parafﬁn sections as described (59). Brieﬂy,
sections were digested with proteinase K (10 mg/ml), hybri-
dized overnight at 688C in a humidiﬁed chamber with probes
labelled with digoxigenin and detected with sheep anti-DIG
antibody conjugated to AP. Colour signals were generated
with BCIP/NBT. Probes used were Bmp4 (a gift from
B. Hogan, Duke University Medical Center, USA), Eya1 (a
gift from Richard Maas, Brigham and Women’s Hospital and
Harvard Medical School, USA), Gdf11 (a gift from S.J. Lee,
Johns Hopkins University School of Medicine, Baltimore,
USA), Gdnf (a gift from A.L. Zimmer, University of Bonn),
Hoxd11 (IMAGE clone; RZPD Germany), Pax2 (a gift from
G. Dressler, Howard Hughes Medical Institute, University of
Michigan) and Ret (a gift from F. Costantini, Columbia Univer-
sity, USA). Apoptotic cells were detected by TUNEL using sec-
tions from parafﬁn-embedded tissues: we used the Promega
Dead-End colourimetric kit with proteinase K digestion for
15 min at room temperature and colour development with AEC.
Explant culture
Nephrogenic ﬁelds (i.e. paired mesonephroi, MDs and adja-
cent MMs) were dissected in ice-cold PBS, and heads used
for genotyping. Tissues were placed on cellulose ﬁlters and
fed with DMEM/F12 (Invitrogen) supplemented with 5%
ITS (Sigma) and antifungal and antibiotic mixture (Sigma).
They were cultured at 378C in a 5% CO2/air atmosphere for
up to 96 h, and the medium was changed every day. In
some experiments, hGDNF (Promega) or mature form of
recombinant hGDF11 (R&D Systems) were added at respect-
ive concentrations of 100 and 50 ng/ml, similar to that used
previously for GDNF (12) or suggested by pilot experiments
for GDF11. Explants were photographed through a dissecting
microscope and ﬁxed with 4% PFA for wholemount Pax2
immunostaining. Explants were embedded in parafﬁn and sec-
tions were immunostained (using a different colour signal) for
either ﬁbronectin, Bcl2 or Itga8.
Numbers of embryos studied
For in vivo morphological analyses between E10 and E11, 30
wild types (þ/þ) and 23 bl/bl mutants were studied. Of the
latter, 16 were at E11. For each ICH/ISH/TUNEL analysis,
between two and ﬁve wild-type and bl/bl mutant embryos
were examined at each stage, allowing the reporting of repro-
ducible data. In a typical explant experiment, all renal tracts
from one embryonic litter from bl/þ parents would be
explanted and then grown with or without exogenous
hGNDF and/or hGDF11. Such litters usually contained 6–10
embryos. Thus, after genotyping, one would ﬁnd around two
þ/þ or bl/bl explants in each experiment, and outcomes of
all these two genotypes were used to generate data sets.
Explant outcomes were compared using Fisher’s exact test.
For these comparisons, we grouped E10 and E11 explants
together because they behaved uniformly in terms of
whether the MMs regressed or not, depending on the
absence or presence of exogenous growth factors.
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